Stryker Corp. (SYK): Price and Financial Metrics

Stryker Corp. (SYK): $354.08

1.85 (+0.53%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

B

SYK Price/Volume Stats

Current price $354.08 52-week high $361.41
Prev. close $352.23 52-week low $249.98
Day low $352.62 Volume 953,700
Day high $355.92 Avg. volume 1,355,702
50-day MA $336.01 Dividend yield 0.9%
200-day MA $297.61 Market Cap 134.53B

SYK Stock Price Chart Interactive Chart >

SYK POWR Grades

  • Growth is the dimension where SYK ranks best; there it ranks ahead of 92.06% of US stocks.
  • SYK's strongest trending metric is Stability; it's been moving down over the last 26 weeks.
  • SYK's current lowest rank is in the Momentum metric (where it is better than 24.39% of US stocks).

SYK Stock Summary

  • SYK has a higher market value than 97.86% of US stocks; more precisely, its current market capitalization is $111,666,233,421.
  • SYK's went public 35.95 years ago, making it older than 89.52% of listed US stocks we're tracking.
  • The volatility of STRYKER CORP's share price is greater than that of merely 2.04% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to STRYKER CORP, a group of peers worth examining would be ETN, ZTS, BSX, GE, and PBR.
  • SYK's SEC filings can be seen here. And to visit STRYKER CORP's official web site, go to www.stryker.com.

SYK Valuation Summary

  • SYK's price/sales ratio is 5.7; this is 35.71% higher than that of the median Healthcare stock.
  • Over the past 243 months, SYK's price/earnings ratio has gone up 4.6.

Below are key valuation metrics over time for SYK.

Stock Date P/S P/B P/E EV/EBIT
SYK 2023-12-29 5.7 6.4 44.0 38.8
SYK 2023-12-28 5.7 6.3 44.0 38.8
SYK 2023-12-27 5.7 6.3 43.9 38.8
SYK 2023-12-26 5.7 6.3 44.0 38.8
SYK 2023-12-22 5.7 6.3 43.7 38.6
SYK 2023-12-21 5.7 6.3 43.5 38.4

SYK Growth Metrics

    Its year over year revenue growth rate is now at 18.44%.
  • Its 2 year cash and equivalents growth rate is now at -63.22%.
  • Its 2 year net cashflow from operations growth rate is now at 22.07%.
SYK's revenue has moved up $1,780,000,000 over the prior 15 months.

The table below shows SYK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 18,449 2,624 2,358
2022-09-30 17,948 2,621 2,457
2022-06-30 17,629 2,665 2,079
2022-03-31 17,430 3,014 2,015
2021-12-31 17,108 3,263 1,994
2021-09-30 16,669 3,500 1,900

SYK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SYK has a Quality Grade of C, ranking ahead of 70.62% of graded US stocks.
  • SYK's asset turnover comes in at 0.492 -- ranking 96th of 186 Medical Equipment stocks.
  • ISRG, ABMD, and BSX are the stocks whose asset turnover ratios are most correlated with SYK.

The table below shows SYK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.492 0.638 0.100
2021-06-30 0.486 0.644 0.114
2021-03-31 0.447 0.628 0.081
2020-12-31 0.450 0.631 0.096
2020-09-30 0.461 0.636 0.113
2020-06-30 0.478 0.633 0.108

SYK Price Target

For more insight on analysts targets of SYK, see our SYK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $287.72 Average Broker Recommendation 1.6 (Moderate Buy)

Stryker Corp. (SYK) Company Bio


Stryker Corporation is an American multinational medical technologies corporation based in KalamazooMichigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. (Source:Wikipedia)


SYK Latest News Stream


Event/Time News Detail
Loading, please wait...

SYK Latest Social Stream


Loading social stream, please wait...

View Full SYK Social Stream

Latest SYK News From Around the Web

Below are the latest news stories about STRYKER CORP that investors may wish to consider to help them evaluate SYK as an investment opportunity.

Stryker Corp's Dividend Analysis

Stryker Corp (NYSE:SYK) recently announced a dividend of $0.8 per share, payable on 2024-01-31, with the ex-dividend date set for 2023-12-28. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Stryker Corp's dividend performance and assess its sustainability.

Yahoo | December 27, 2023

Is It Smart To Buy Stryker Corporation (NYSE:SYK) Before It Goes Ex-Dividend?

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Stryker...

Yahoo | December 23, 2023

Stryker buys joint replacement business Serf Sas

The purchase is expected to complement Stryker’s business in Europe and its joint replacement portfolio.

Yahoo | December 20, 2023

4 Orthobiologic Stocks Set To Soar In 2024

Welcome to the transformative landscape of orthobiologics, where cutting-edge treatments utilize the body's own cells and healing factors to reverse orthoarthritis effects and expedite recovery fro...

Yahoo | December 19, 2023

HAE vs. SYK: Which Stock Is the Better Value Option?

HAE vs. SYK: Which Stock Is the Better Value Option?

Yahoo | December 18, 2023

Read More 'SYK' Stories Here

SYK Price Returns

1-mo 1.37%
3-mo 23.14%
6-mo 25.16%
1-year 29.28%
3-year 59.14%
5-year 89.11%
YTD 18.24%
2023 23.80%
2022 -7.42%
2021 10.22%
2020 18.17%
2019 35.33%

SYK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SYK Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!